Ellagic acid, a polyphenolic compound, selectively induces ROS-mediated apoptosis in cancerous B-lymphocytes of CLL patients by directly targeting mitochondria
Open Access
- 1 December 2015
- journal article
- research article
- Published by Elsevier in Redox Biology
- Vol. 6, 461-471
Abstract
No abstract availableKeywords
Funding Information
- Shahid Beheshti University of Medical Sciences (1392-1-132-1183)
This publication has 49 references indexed in Scilit:
- Novel agents for chronic lymphocytic leukemiaJournal of Hematology & Oncology, 2013
- Therapeutic advancement of chronic lymphocytic leukemiaJournal of Hematology & Oncology, 2012
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- Evasion of Apoptosis as a Cellular Stress Response in CancerInternational Journal of Cell Biology, 2010
- Mitochondrial Energetics and TherapeuticsAnnual Review of Pathology: Mechanisms of Disease, 2010
- Natural Phenolic Compounds From Medicinal Herbs and Dietary Plants: Potential Use for Cancer PreventionNutrition and Cancer, 2009
- A Novel Paradigm to Trigger Apoptosis in Chronic Lymphocytic LeukemiaCancer Research, 2009
- Perspectives for Cancer Prevention With Natural CompoundsJournal of Clinical Oncology, 2009
- Mitochondrial Reactive Oxygen Species Production in Excitable Cells: Modulators of Mitochondrial and Cell FunctionAntioxidants & Redox Signaling, 2009
- Forodesine, an inhibitor of purine nucleoside phosphorylase, induces apoptosis in chronic lymphocytic leukemia cellsBlood, 2006